Status:
COMPLETED
Twelve Month Follow-Up of CP0108
Lead Sponsor:
DUSA Pharmaceuticals, Inc.
Conditions:
Actinic Keratosis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the long-term safety and efficacy of Levulan PDT in subjects with multiple actinic keratosis of the upper extremities who received treatment as part of the DU...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subject must have been enrolled in the DUSA-CP0108 study, completed their assigned treatment and Visit 6 (Week 12).
Exclusion
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
206 Patients enrolled
Trial Details
Trial ID
NCT02209012
Start Date
August 1 2014
End Date
April 1 2016
Last Update
September 23 2016
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Center For Dermatology Clinical Research, Inc.
Fremont, California, United States, 94538
2
UCSD Dermatology
San Diego, California, United States, 92122
3
Center for Clinical and Cosmetic Research
Aventura, Florida, United States, 33180
4
MOORE Clinical Research, Inc
Brandon, Florida, United States, 33609